Clinical trials
Recruiting Adenocarcinoma trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
21 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2017 | 1 |
| 2020 | 1 |
| 2022 | 1 |
| 2023 | 2 |
| 2024 | 3 |
| 2025 | 8 |
| 2026 | 5 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 21 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| First Affiliated Hospital of Fujian Medical University | 3 |
| Astellas Pharma Global Development, Inc. | 2 |
| Shanghai Zhongshan Hospital | 2 |
| Acerand Therapeutics (Hong Kong) Limited | 1 |
| Akeso | 1 |
| AstraZeneca | 1 |
| Chinese University of Hong Kong | 1 |
| Essen Biotech | 1 |
| Fudan University | 1 |
| FutureGen Biopharmaceutical (Beijing) Co., Ltd | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Adenocarcinoma | 21 |
| Stomach Neoplasms | 8 |
| Prostatic Neoplasms | 7 |
| Esophageal Neoplasms | 3 |
| Digestive System Neoplasms | 2 |
| Gastrointestinal Neoplasms | 2 |
| Neoplasms | 2 |
| Ascites | 1 |
| Bronchial Neoplasms | 1 |
| Carcinoma | 1 |
Trials
Showing 1 to 21 of 21. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.